Metagenomic Sequencing Market Drivers, Opportunities, Trends, and Forecasts by 2031

Coverage: By Product and Service (Reagents and Consumables, Instruments, Services, Analysis and Data Interpretation Solutions); Workflow (Sample Processing and Library Preparation, Sequencing, Data Processing and Analysis); Technology (16s Rrna Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing and De Novo Assembly, Metatranscriptomics); Application (Drug Discovery, Ecological and Environmental Applications, Clinical Diagnostics, Soil Microbiome Applications, Industrial Applications, Veterinary Applications, Other Applications) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2023 | Base Year: 2024 | Forecast Period: 2025-2031
  • Status : Data Released
  • Report Code : TIPRE00006697
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : January 27, 2025
Metagenomic Sequencing Market Drivers, Opportunities, Trends, and Forecasts by 2031
Report Date: January 27, 2025   |   Report Code: TIPRE00006697 Email: sales@theinsightpartners.com

2024 Market Size

US$ 3,060.43 Mn

Base year value

2031 Forecast

US$ 8,442.82 Mn

Projected by 2031

CAGR 2025-2031

15.6 %

Growth rate

Addressable Market

US$ 39,884.86 Mn

(2025-2031)

The Metagenomic Sequencing Market size is expected to reach US$ 8,443 million by 2031. The market is anticipated to register a CAGR of 15.6% during 2025–2031.

The Metagenomic Sequencing Market report covers analysis By Product and Service (Reagents and Consumables, Instruments, Services, Analysis and Data Interpretation Solutions); Workflow (Sample Processing and Library Preparation, Sequencing, Data Processing and Analysis); Technology (16s Rrna Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing and De Novo Assembly, Metatranscriptomics); Application (Drug Discovery, Ecological and Environmental Applications, Clinical Diagnostics, Soil Microbiome Applications, Industrial Applications, Veterinary Applications, Other Applications). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Metagenomic Sequencing Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Metagenomic Sequencing Market Segmentation Product and Service

  1. Reagents and Consumables
  2. Instruments
  3. Services
  4. Analysis and Data Interpretation Solutions

Workflow

  1. Sample Processing and Library Preparation
  2. Sequencing
  3. Data Processing and Analysis

Technology

  1. 16s Rrna Sequencing
  2. Shotgun Metagenomic Sequencing
  3. Whole-Genome Sequencing and De Novo Assembly
  4. Metatranscriptomics

Application

  1. Drug Discovery
  2. Ecological and Environmental Applications
  3. Clinical Diagnostics
  4. Soil Microbiome Applications
  5. Industrial Applications
  6. Veterinary Applications
  7. Other Applications

Market Research Highlights

  • Global market for Metagenomic Sequencing was valued at US$ 3,060.43 Million in 2024
  • Annual market size is expected to reach US$ 8,442.82 Million by 2031
  • Total addressable market (TAM) during 2025-2031 is projected to reach approximately US$ 39,884.86 Million
  • Market is anticipated to register a CAGR of 15.6% during the forecast period
  • The United States represents a key market, supported by Increased Research Grants, Advancements in Sequencing Technology, Increasing Demand for Microbiome Studies, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Growth Opportunity in Microbiome Research, Cost-Effective Innovations, Public Health and Disease Outbreak Control are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Illumina, Inc., Thermo Fisher Scientific, Inc., QIAGEN N.V., PerkinElmer, Oxford Nanopore Technologies Ltd., BGI Group, Macrogen Inc., GENEWIZ, Eurofins Scientific, Novogene Corporation, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Metagenomic Sequencing Market: Strategic Insights

metagenomic-sequencing-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Metagenomic Sequencing Market Growth Drivers

  1. Increased Research Grants: Growing research grants and government funding in genomics are key to market growth, enabling the development of better diagnostic tools and a deeper understanding of the microbial community for health and agriculture applications.
  2. Advancements in Sequencing Technology: The rise of cost-effective sequencing methods and advanced computational tools improves analysis accuracy, accelerating market trends. These technological advancements also drive the adoption of metagenomics in diagnostics, environmental studies, and pharmaceuticals.
  3. Increasing Demand for Microbiome Studies: Rising public awareness of the health impacts of the microbiome is fueling demand for sequencing services. Precision medicine, food safety, and environmental monitoring are key drivers of competitive market growth.

Metagenomic Sequencing Market Future Trends

  1. Metagenomic Sequencing for Diagnostics: The increasing use of metagenomic sequencing to diagnose complex microbial communities is driving personalized medicine and improving patient care. Advances in genomic technology are key market drivers, with collaborations between leaders and health institutions. SWOT analysis indicates strong growth potential, though cost concerns remain.
  2. Advances in Sequencing Technologies: Next-gen and high-throughput sequencing technologies are revolutionizing metagenomic research and its applications. Major players are investing in R&D to enhance speed and accuracy. SWOT analysis highlights technological innovation as a strength, while the pharmaceutical and agricultural sectors are key drivers. Challenges include high initial costs and regulatory hurdles.
  3. Applications in Microbiome Research: Metagenomic sequencing is central to microbiome studies, supporting precision medicine and product development across various sectors. Market strategies involve expanding collaborations with research bodies, and cross-sector integration, especially in agriculture and nutrition, is changing market dynamics. SWOT analysis shows potential for accessing new markets, but complexities in data interpretation may delay uptake and impact market forecasts.

Metagenomic Sequencing Market Opportunities

  1. Growth Opportunity in Microbiome Research: Metagenomic sequencing is crucial for studying human microbiomes and environmental biodiversity, presenting a growth opportunity for businesses targeting this area. Rising awareness in North America highlights a promising market outlook.
  2. Cost-Effective Innovations: Lowering sequencing costs enables smaller labs and research institutions to access metagenomics, allowing companies with affordable solutions to expand their market presence and geographic reach.
  3. Public Health and Disease Outbreak Control: Real-time disease monitoring using metagenomic data offers growth potential in pathogen research. Companies can increase market share by investing in capabilities that support public health and disease outbreak control.

Metagenomic Sequencing Market Report Scope

Report Attribute Details
Market size in 2024 US$ 3,060.43 Million
Market Size by 2031 US$ 8,442.82 Million
Global CAGR (2025 - 2031) 15.6%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product and Service
  • Reagents and Consumables
  • Instruments
  • Services
  • Analysis and Data Interpretation Solutions
By Workflow
  • Sample Processing and Library Preparation
  • Sequencing
  • Data Processing and Analysis
By Technology
  • 16s Rrna Sequencing
  • Shotgun Metagenomic Sequencing
  • Whole-Genome Sequencing and De Novo Assembly
  • Metatranscriptomics
By Application
  • Drug Discovery
  • Ecological and Environmental Applications
  • Clinical Diagnostics
  • Soil Microbiome Applications
  • Industrial Applications
  • Veterinary Applications
  • Other Applications
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • QIAGEN N.V.
  • PerkinElmer
  • Oxford Nanopore Technologies Ltd.
  • BGI Group
  • Macrogen Inc.
  • GENEWIZ
  • Eurofins Scientific
  • Novogene Corporation

Metagenomic Sequencing Market Players Density: Understanding Its Impact on Business Dynamics

The Metagenomic Sequencing Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

metagenomic-sequencing-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Metagenomic Sequencing Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Metagenomic Sequencing Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

Key companies of this market are: Illumina, Inc., Thermo Fisher Scientific, Inc., QIAGEN N.V., PerkinElmer, Oxford Nanopore Technologies Ltd., BGI Group, Macrogen Inc., GENEWIZ, Eurofins Scientific

Key future trends in this market are - Rising Use in Clinical Diagnostics, Technological Innovations, Applications in Microbiome Research

The Metagenomic Sequencing Market is estimated to witness a CAGR of 15.6% from 2025 to 2031.

The major factors driving the Market are: Rising research funding, Technological advancements in sequencing, Growing interest in microbiomes
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA